SEC Form 4 · accession 0001209191-15-044996
Insys Therapeutics, Inc. · INSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Fourteau
Director
Period of report
May 19, 2015
Accepted (ET)
May 20, 2015 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 19, 2015 | S | 2,969 | $60.00 | D | 67,031 | D | |
| Common Stock | May 20, 2015 | S | 6,095 | $60.00 | D | 60,936 | D |
Table II — derivative securities
No Table II lines on this filing.